PHARMA LITERATI

I welcome all the readers of this blog whether they belong to pharmacy profession or any other related field. The initiative taken by Pharma literati is to be applauded and genuflected and I am agog to write for this blog in future and especially for the upliftment of pharmacy professional s from my beautiful valley called Kashmir . A very minute and small contribution from each one of us should bring laurels to the field of pharmacy. It is always that single drops contribute for making oceans.   Since the inception of pharmacy from 9 th century from Middle East the profession of pharmacy has undergone so many changes. And overall scenario lies that India is going to emerge as super power in pharmaceutical industry by the year 2020 . I hope this Vision 2020 is 100% up to our expectations and prognostications from economists.   Greeks were the patrons of pharmacy and all the pharma knowing people might be well aware of this fact that word pharmacy originated from ...

Dear All, Every week of thousands of patent applications are published in India. The  patent applications filed by the pharma academic research institutes in India  go un-noticed.   We publish a list of Indian applications published related to pharma academics. This would provide us an idea about the kind of academic research being carried out in these institutes. For details of these patents, please write back to us at  pharmaliterati@gmail.com   Indian patent applications published on 29th May 2015 Invention Application No Inventors Institute Hydrogel-Linked Nanocarrier Systems For Intravesical Drug Delivery 985/MUM/2013 1)Prof. Rinti Banerjee  2)Shruti Guha Sarkar Indian Institute of Technology, Bombay. Novel Benzimidazoles As Antimicrobials 1323/KOL/2013 1)Ganguly,Swastika  2)Yadav,Geeta Dept. of Pharmaceutical Sc...

Dear All, We had posted about bloggers joining our team. See http://pharmaliterati.blogspot.in/2015/05/bloggers-required.html We are pleased to welcome our first blogger, Mrs Mohi Durakshan from Srinagar, Jammu & Kashmir. She is currently working as a pharmacist in "Sher-i-Kashmir Institute of Medical Sciences" . She brings with her 14 years of experience as a pharmacist.   She has done her B. Pharma in 1997 from University of Kashmir and M. Pharma with distinction from University of Kashmir. She is also a freelancer for an English newspaper.   We welcome Mohi to our team and wish a luck in the endeavour. To join as a blogger with Pharma Literati team, send your CV to pharmaliterati@gmail.com   Team Pharma Literati.    

Who can join RGNIIPM Training: ·    Professors, Lecturers, Research scholars etc.  ·    Students from perusing Law or Science or commerce etc. ·    Lawyers, IPR attorney / Patent /TMR agents / Legal Advisors, Consultants etc. ·    Professionals from Industries, Research & Development and Scientists etc. ·    Officials from IPR cell, KPO / LPO  professionals, etc. ·    Doctors, Engineers, Pharma professionals , CA, Company Secretary etc. ·    OR Any interested person.   Venue of Training : Rajiv Gandhi National Institute of Intellectual Property Management, Behind Air India, Near Nagpur university, Civil Lines, Nagpur – 440 001   Training Timing :     9.30 AM to 6.00 PM Training Schedule: Duration of training program Training Program Training Program to be held on Normal Training Fees (Rs) Fee for Students / research Scholar (...

In a welcome move by India's leading pharmaceutical drug producer Glenmark Pharmaceuticals, the company has reduced the price for Erleva (erlotinib), Geftib (gefitinib) and Pexotra (pemetrexed) by about 55-70%. These drugs are used for the treatment of lung cancer.   DNA reports here, http://www.dnaindia.com/money/report-glenmark-cuts-lung-cancer-drug-price-2089524   The new prices of cancer drugs are as follows: Erleva (150 mg, 30 tablets) is Rs 9,700 (drop of 67.66% ), Geftib tablets 250 mg (1 box of 3 strips of 10 tablets each) is Rs 3,999 (drop of 63.63% ); Pexotra injection 100 mg (1 vial) is Rs 2,000 (fall of 56% ) and Pexotra injection 500 mg (1 vial) is Rs 8,000 (fall of 60.87%).   Sujesh Vasudevan, executive VP, Glenmark, told DNA that more price reductions in different segments of the company's cancer drug portfolio are on the cards.    

Dear All, NMIMS announces the admissions for Executive MBA in Pharmaceutical Management .   This is a highly focused course for those working men and women executives/managers who are already graduates and are working in Pharmaceutical Companies. This is an opportunity for them, to learn from the best in the industry while they continue to work. The program allows them to understand the business holistically & take on greater business responsibilities at work thereby enhancing their career prospects. The tailor-made weekend program provides them an opportunity to pursue their MBA degree despite their busy work schedule.   Fees: 4,50,000 Rs.   Eligibility: Graduation + 3 years work experience.   Deadline for application: 5th July 2015.     For details: http://www.nmimssbm.org/academics/programs/executive-mba-pharmaceutical-management/    

European Regulatory agency (EMA) recently re-confirmed the suspension of drug suspensions of various products. This list includes products of various companies including Abbott Apotex, Mylan, Ratiopharm, Teva, Takeda, Accord, Generics (UK) ltd, Glenmark, Sandoz, Wockhardt, Actavis, Stada, Orion, Ranbaxy, Zydus, Lupin, Betapharm, Panacea Biotec, Unichem, Genepharm, Torrent, Dr. Reddy's labs, Alembic, FDC Pharma, Morningside healthcare See the entire list of products and the companies at http://www.ema.europa.eu/docs/en_GB/document_library/Other/2015/05/WC500187078.pdf  

Dear All, We @ pharma literati require bloggers for our blog. This is an opportunity to work with a team of passionate pharma professionals, students and faculties across India with lots of perks and benefits and learning opportunities.  This is a part time activity and the intellectuals need to put 3-4 hours a week as per the requirement from their own location.  As such, there is no remuneration available with the position. However, a certificate would be provided by team Pharma Literati. Please feel free to get in touch along with your CV to pharmaliterati@gmail.com Team Pharma Literati

Dear Readers,          Thanks for the overwhelming response to the blog and the posts. In an effort to bridge the gap between industry and the academia, we would be publishing the interviews of personnel in the industry, their expectations from the academia and their viewpoints about the pharmacy profession and industry in India. In this series, we would line up interviews from academia as well. If you believe, your opinion matters to the industry and the students, do let us know and we would arrange for the interview soon.  Please write us back at pharmaliterati@gmail.com Team Pharma Literati. 

Dear All, Every week of thousands of patent applications are published in India. The  patent applications filed by the pharma academic research institutes in India  go un-noticed. We publish a list of Indian applications published related to pharma academics. This would provide us an idea about the kind of academic research being carried out in these institutes. For details of these patents, please write back to us at  pharmaliterati@gmail.com Indian patent applications published on 22nd May 2015 Invention Application No Inventors Institute A Solid Catalyst Composition And A Process For Its Preparation 3358/DEL/2013 1)Ali Amjad  2)Kumar Dinesh Thapar University

Dear All, Professor K K Bhutani, director, NIPER, Mohali and Dr VSV Vadlamudi Rao, president, Indian Pharmaceutical Association, Mumbai recently released a book series on Naobiomedicine in Chandigarh. The book is published by M/s Studium Press, Houston, USA, with ISBN No.: 1-62699-051-6. The details of the six- volume series include: Volume Details Editors 1 Nanomedicine ·     Prof Jagat R Kanwar, Deakin University, Australia; ·     Prof O P Katare, Panjab University, India. 2 Nanopharmaceuticals ·     Prof Kamalinder K Singh; University of Central Lancashire, UK; ·     Dr Gurvinder S Rekhi, University of Georgia, USA. 3 Nanotheranostics ·    Prof Mandip S Sachdeva; Florida A&M University, USA; ...